Home›Companies›Biotech & Pharma›iReprogram

iReprogram, Inc

Software predicts how to change cells for developers of patient-specific therapies.

Updated Nov 9, 2026·Latest SEC filing Aug 13, 2026·Suggest an edit

About iReprogram

iReprogram is a private company based in Ann Arbor, Michigan, incorporated in 2022 in Delaware. It has reported $0 raised in one offering on Form D since August 2026. Its chief executive is Pradeep Seneviratne.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Not yetAug 13, 2026$0of $25.0M target0—DebtRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on iReprogram's Form D filed Aug 13, 2026.

Pradeep Seneviratne
Pradeep Seneviratne
Chief Executive Officer

Sources

  1. SECiReprogram, Inc filing history
  2. CompanyOur Company